151 related articles for article (PubMed ID: 23974498)
1. Differentially-expressed genes in Candida albicans exposed to ε-poly-L-lysine.
Ye RS; Zhang ZH; Xu HY; Xu F; Aguilar ZP; Xiong YH; Zeng ZL; Wei H
Biotechnol Lett; 2013 Dec; 35(12):2147-53. PubMed ID: 23974498
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Candida albicans growth by brominated furanones.
Duo M; Zhang M; Luk YY; Ren D
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
Shafreen RM; Muthamil S; Pandian SK
Appl Microbiol Biotechnol; 2014 Aug; 98(15):6775-85. PubMed ID: 24723295
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
Zeng YB; Qian YS; Ma L; Gu HN
Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
[TBL] [Abstract][Full Text] [Related]
5. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression.
Khodavandi A; Harmal NS; Alizadeh F; Scully OJ; Sidik SM; Othman F; Sekawi Z; Ng KP; Chong PP
Phytomedicine; 2011 Dec; 19(1):56-63. PubMed ID: 21924600
[TBL] [Abstract][Full Text] [Related]
6. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
Kabir MA; Hussain MA
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
[TBL] [Abstract][Full Text] [Related]
7. Effect of plagiochin E, an antifungal macrocyclic bis(bibenzyl), on cell wall chitin synthesis in Candida albicans.
Wu XZ; Cheng AX; Sun LM; Lou HX
Acta Pharmacol Sin; 2008 Dec; 29(12):1478-85. PubMed ID: 19026167
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD
J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599
[TBL] [Abstract][Full Text] [Related]
9. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
10. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
11. Glabridin induces overexpression of two major apoptotic genes, MCA1 and NUC1, in Candida albicans.
Nabili M; Moazeni M; Hedayati MT; Aryamlo P; Abdollahi Gohar A; Madani SM; Fathi H
J Glob Antimicrob Resist; 2017 Dec; 11():52-56. PubMed ID: 28844974
[TBL] [Abstract][Full Text] [Related]
12. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
13. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
14. Divergence of eukaryotic secretory components: the Candida albicans homolog of the Saccharomyces cerevisiae ++Sec20 protein is N terminally truncated, and its levels determine antifungal drug resistance and growth.
Weber Y; Santore UJ; Ernst JF; Swoboda RK
J Bacteriol; 2001 Jan; 183(1):46-54. PubMed ID: 11114899
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum-derived reactive oxygen species (ROS) is involved in toxicity of cell wall stress to Candida albicans.
Yu Q; Zhang B; Li J; Zhang B; Wang H; Li M
Free Radic Biol Med; 2016 Oct; 99():572-583. PubMed ID: 27650297
[TBL] [Abstract][Full Text] [Related]
16. The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans.
Staniszewska M; Bondaryk M; Zielińska P; Urbańczyk-Lipkowska Z
J Antibiot (Tokyo); 2014 Jun; 67(6):425-32. PubMed ID: 24690909
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain.
Yan L; Zhang JD; Cao YB; Gao PH; Jiang YY
J Proteome Res; 2007 Jun; 6(6):2248-56. PubMed ID: 17432892
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype.
Fitzgerald-Hughes DH; Coleman DC; O'Connell BC
Antimicrob Agents Chemother; 2007 Aug; 51(8):2793-800. PubMed ID: 17485506
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
[TBL] [Abstract][Full Text] [Related]
20. Genomic response programs of Candida albicans following protoplasting and regeneration.
Castillo L; Martínez AI; Garcerá A; García-Martínez J; Ruiz-Herrera J; Valentín E; Sentandreu R
Fungal Genet Biol; 2006 Feb; 43(2):124-34. PubMed ID: 16455273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
